These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2238538)

  • 21. Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition.
    Ottaviani JI; Actis-Goretta L; Villordo JJ; Fraga CG
    Biochimie; 2006; 88(3-4):359-65. PubMed ID: 16330143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max).
    Mallikarjun Gouda KG; Gowda LR; Rao AG; Prakash V
    J Agric Food Chem; 2006 Jun; 54(13):4568-73. PubMed ID: 16786999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy.
    Batlle D; Soler MJ; Wysocki J
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):250-7. PubMed ID: 18408475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plant food-derived Angiotensin I converting enzyme inhibitory peptides.
    Guang C; Phillips RD
    J Agric Food Chem; 2009 Jun; 57(12):5113-20. PubMed ID: 19449887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive peptides derived from food proteins.
    Yamamoto N
    Biopolymers; 1997; 43(2):129-34. PubMed ID: 9216248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative structure-activity relationship study of bitter di- and tri-peptides including relationship with angiotensin I-converting enzyme inhibitory activity.
    Wu J; Aluko RE
    J Pept Sci; 2007 Jan; 13(1):63-9. PubMed ID: 17117396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of metallopeptidases by flavonoids and related compounds.
    Bormann H; Melzig MF
    Pharmazie; 2000 Feb; 55(2):129-32. PubMed ID: 10723772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoselective inhibition of glutamate carboxypeptidase by organophosphorus derivatives of glutamic acid.
    Mallari JP; Choy CJ; Hu Y; Martinez AR; Hosaka M; Toriyabe Y; Maung J; Blecha JE; Pavkovic SF; Berkman CE
    Bioorg Med Chem; 2004 Nov; 12(22):6011-20. PubMed ID: 15498677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Eznzymatic conversions of ortho-nitrophenyl organophosphorus compounds in the tissues of white rats].
    Galebskaia LV; Egorov VI; Shcherbak IG
    Vopr Med Khim; 1976; 22(2):191-4. PubMed ID: 1030887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives.
    Stanton JL; Gruenfeld N; Babiarz JE; Ackerman MH; Friedmann RC; Yuan AM; Macchia W
    J Med Chem; 1983 Sep; 26(9):1267-77. PubMed ID: 6310112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [biological activity of phosphorus analogs of amino acids].
    Kukhar' VP; Solodenko NM; Solodenko VA
    Ukr Biokhim Zh (1978); 1988; 60(6):95-111. PubMed ID: 3070888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin converting enzyme inhibitors. (Mercaptoaroyl)amino acids.
    Menard PR; Suh JT; Jones H; Loev B; Neiss ES; Wilde J; Schwab A; Mann WS
    J Med Chem; 1985 Mar; 28(3):328-32. PubMed ID: 2983075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Organophosphorus compounds: classification and enzyme reactions].
    Bosak A
    Arh Hig Rada Toksikol; 2006 Dec; 57(4):445-57. PubMed ID: 17265684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of thermolysin and carboxypeptidase A by phosphoramidates.
    Kam CM; Nishino N; Powers JC
    Biochemistry; 1979 Jul; 18(14):3032-8. PubMed ID: 465451
    [No Abstract]   [Full Text] [Related]  

  • 36. Structure and conformation of a novel inhibitor of angiotensin I converting enzyme--a tripeptide containing phosphonic acid.
    Hirayama N; Kasai M; Shirahata K
    Int J Pept Protein Res; 1991 Jul; 38(1):20-4. PubMed ID: 1938102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of N-mercaptoacylamino acids on inhibition of angiotensin I converting enzyme.
    Funae Y; Komori T; Sasaki D; Yamamoto K
    Jpn J Pharmacol; 1978 Dec; 28(6):925-7. PubMed ID: 218033
    [No Abstract]   [Full Text] [Related]  

  • 38. Some enzymatic properties of peptidyl dipeptide hydrolase (angiotensin I-converting enzyme).
    Oshima G; Nagasawa K
    J Biochem; 1977 Jan; 81(1):57-63. PubMed ID: 191438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of acylated amino acids and acylated amino acid analogs on microbial antitumor screen.
    Otani TT; Briley MR
    J Pharm Sci; 1978 Apr; 67(4):520-6. PubMed ID: 417168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The microbial modification of A58365A, an angiotensin converting enzyme inhibitor.
    Mynderse JS; Fukuda DS; Hunt AH
    J Antibiot (Tokyo); 1995 May; 48(5):425-7. PubMed ID: 7797445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.